Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

APPELBAUM

Showing results (581-590 of 2,379) with videos related to

Pageof 238
Sort By:
The Thoracic and Cardiovascular Surgeon|December 1, 1980
Afterload reduction and cardiac output in patients after mitral valve surgeryA Appelbaum, D Bitran, G Merin, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C Appelbaum
Disease Models & Mechanisms|September 25, 2016
Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafishDavid Zada, Adi Tovin, Tali Lerer-Goldshtein, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1991
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsP C Appelbaum, S K Spangler, M R Jacobs
Antimicrobial Agents and Chemotherapy|September 25, 2004
Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporinDianne B Hoellman, Glenn A Pankuch, Peter C Appelbaum
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodologyM A Visalli, M R Jacobs, P C Appelbaum
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 4, 2014
Reduced synaptic density and deficient locomotor response in neuronal activity-regulated pentraxin 2a mutant zebrafishIdan Elbaz, Tali Lerer-Goldshtein, Hitoshi Okamoto, et al.
Southern Medical Journal|June 1, 1988
Pseudomonas paucimobilis empyema after cardiac transplantationT L Cover, P C Appelbaum, R C Aber
Schizophrenia Research|November 25, 2020
A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoiseRyan E Lawrence, Paul S Appelbaum, Jeffrey A Lieberman
Pageof 238

Showing results (581-590 of 2,379) with videos related to

Sort By:
Pageof 238
The Thoracic and Cardiovascular Surgeon|December 1, 1980
Afterload reduction and cardiac output in patients after mitral valve surgeryA Appelbaum, D Bitran, G Merin, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobesS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|November 1, 1994
Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteriaS K Spangler, M R Jacobs, P C Appelbaum
Disease Models & Mechanisms|September 25, 2016
Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafishDavid Zada, Adi Tovin, Tali Lerer-Goldshtein, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1991
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agentsP C Appelbaum, S K Spangler, M R Jacobs
Antimicrobial Agents and Chemotherapy|September 25, 2004
Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporinDianne B Hoellman, Glenn A Pankuch, Peter C Appelbaum
The Journal of Antimicrobial Chemotherapy|January 1, 1996
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodologyM A Visalli, M R Jacobs, P C Appelbaum
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 4, 2014
Reduced synaptic density and deficient locomotor response in neuronal activity-regulated pentraxin 2a mutant zebrafishIdan Elbaz, Tali Lerer-Goldshtein, Hitoshi Okamoto, et al.
Southern Medical Journal|June 1, 1988
Pseudomonas paucimobilis empyema after cardiac transplantationT L Cover, P C Appelbaum, R C Aber
Schizophrenia Research|November 25, 2020
A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoiseRyan E Lawrence, Paul S Appelbaum, Jeffrey A Lieberman
Pageof 238